Corrigendum: Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma

Front Oncol. 2021 Jul 23:11:736373. doi: 10.3389/fonc.2021.736373. eCollection 2021.

Ying Chen^{1

2}, Rui Li², Yuqi Zhu^{2

3}, Sixia Zhong², Jinjun Qian², Dongqing Yang², Artur Jurczyszyn⁴, Meral Beksac⁵, Chunyan Gu^{1

2}, Ye Yang^{2

6}

¹ The Third Affifiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
² School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
³ Department of Internal Medicine, University of Iowa, Iowa City, IA, United States.
⁴ Department of Hematology, Collegium Medicum, Jagiellonian University, Kraków, Poland.
⁵ Department of Hematology, School of Medicine, Ankara University, Ankara, Turkey.
⁶ Key Laboratory for Combination of Acupuncture and Chinese Materia Medica of Chinese Ministry of Education, Nanjing University of Chinese Medicine, Nanjing, China.

Abstract

[This corrects the article DOI: 10.3389/fonc.2020.00767.].

Keywords: artemisinin; dexamethasone; dihydroartemisinin; drug resistance; multiple myeloma.